Brief: Deciphera Pharma Reports Q2 2022 Financial Results
04/08/2022 12:37
Aug 4 (Reuters) - Deciphera Pharmaceuticals Inc DCPH.O :
* DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER
2022
FINANCIAL RESULTS
* DECIPHERA PHARMACEUTICALS INC - QTRLY TOTAL REVENUES
$32.5
MILLION VERSUS $23.6 MILLION
* DECIPHERA PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE
$0.6
Source text for Eikon: ID:nBw2nSMmqa
Further company coverage: DCPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions